Brand Name: SGONEK
Price: $30 -$75/Kilogram
Place of Origin: Shaanxi, China
Certification: ISO FDA SG COA MSDS
Grade: Food Grade Pharmaceutical Grade
Payment Terms: T/T, Western Union, MoneyGram
| Product Name: | Enrofloxacin HCL | Cas No.: | 112732-17-9 |
| Molecular Formula: | C19H23ClFN3O3 | Purity: | 99%min |
| Brand Name: | SGONEK | Certification: | ISO FDA SG COA MSDS |
| Product Name | Enrofloxacin HCL |
| CAS No. | 112732-17-9 |
| Purity | 99% |
| Appearance | White Powder |
| Molecular Formula | C19H23ClFN3O3 |
| EINECS No. | 1806241-263-5 |
|
Description: Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect. |
|
|
Item |
Standard |
Result |
|
Appearance |
Light-yellow or light-yellow orange crystalline powder |
Light-yellow crystalline Powder |
|
Melting range |
Between 221°C and 226°C |
223.0°C~225.5°C |
|
Identification |
Meet the requirements |
Meet the requirements |
|
Fluoroquinolonic acid |
Not more than 0.2% |
<0.2% |
|
Ciprofloxacin |
Not more than 1.0% |
0.15% |
|
Loss on drying |
Not more than 3.0% |
0.1% |
|
Residue on ignition |
Not more than 0.2% |
0.04% |
|
Heavy metals |
Not more than 20ppm |
<20ppm |
|
Assay(on the dried basis) |
Not less than 98.5% |
99.1% |
Dogs and Cats
The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Cattle
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Pigs
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
